Cipla’s arm to acquire two manufacturing undertakings

06 Sep 2014 Evaluate

Cipla’s wholly owned subsidiary - Medispray Laboratories, has received an approval for acquisition of two manufacturing undertakings. A significant portion of the capacities of the two undertakings are dedicated for the manufacture of Cipla’s products. The acquisition of the aforesaid undertakings is expected to yield operational synergies. The board of directors at their meeting held on September 05, 2014 has approved for the same.

The consideration for the above two transactions are Rs 29 crore and Rs 71.93 crore respectively. The first manufacturing facility located at Goa is owned by Okasa and the second manufacturing facility located at Satara (Maharashtra) is owned by Okasa Pharma, the entities controlled by relatives of the promoters hold majority interest in the companies which own the aforesaid undertakings.

The consideration for these transactions was supported on the basis of valuation reports from Price Waterhouse & Co. LLP and fairness opinions provided by Kotak Mahindra Capital Company.

Cipla Share Price

1497.00 -8.05 (-0.53%)
29-Dec-2025 13:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.45
Dr. Reddys Lab 1264.70
Cipla 1497.00
Zydus Lifesciences 903.70
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×